Patent holdings for IPC class C07D 207/27

Total number of patents in this class: 339

10-year publication summary

23
25
18
27
24
19
29
26
21
12
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Zhejiang Huahai Pharmaceutical Co., Ltd.
209
14
Modernatx, Inc.
1263
9
Novartis AG
10849
7
Bristol-myers Squibb Company
4898
7
ISP Investments Inc.
461
7
Suzhou Brighthope PharmaTech Co., Ltd
12
7
E. I. du Pont de Nemours and Company
4082
6
California Institute of Technology
3976
6
PTC Therapeutics, Inc.
483
6
Zhejiang Huahai Zhicheng Pharmaceutical Co., Ltd
29
6
Eli Lilly and Company
3842
4
FMC Corporation
844
4
PharmaZell GmbH
42
4
Queen's University at Kingston
535
4
Shanghai Syncores Technologies Inc. Ltd
33
4
Bayer Pharma AG
1052
3
Daikin Industries, Ltd.
9995
3
Takeda Pharmaceutical Company Limited
2713
3
Astellas Pharma Inc.
1088
3
Consejo Superior de Investigaciones Cientificas (csic)
1369
3
Other owners 229